CNS Pharmaceuticals, Inc.
CNSP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $4 | $133 |
| - Cash | $10 | $12 | $13 | $6 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$10 | -$12 | -$9 | $127 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$2 | -$4 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -104.35 | -77.04 | -18.96 | -2.96 |
| % Growth | -35.4% | -306.3% | -540.5% | – |
| Operating Cash Flow | -$2 | -$5 | -$3 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$5 | -$3 | -$5 |